程序性死亡受体1/程序性死亡受体配体1抑制剂一线治疗晚期驱动基因阴性非鳞非小细胞肺癌的临床综合评价
杨晓丽, 周豪, 吴怡婷, 胡春海
Clinical comprehensive evaluation of PD-1/PD-L1 inhibitors as first-line treatment for advanced driver-gene negative non-squamous non-small cell lung cancer
Xiaoli YANG, Hao ZHOU, Yiting WU, Chunhai HU
临床药物治疗杂志
.
2025, (10): 58
-67
.
DOI: 10.3969/j.issn.1672-3384.2025.10.010
